This company listing is no longer active
Karo Pharma Management
Management criteria checks 1/4
Key information
Christoffer Lorenzen
Chief executive officer
kr12.6m
Total compensation
CEO salary percentage | 35.8% |
CEO tenure | 3.3yrs |
CEO ownership | n/a |
Management average tenure | 2.2yrs |
Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality
Feb 24Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?
Feb 22Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?
Feb 01CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -kr190m |
Mar 31 2022 | n/a | n/a | -kr141m |
Dec 31 2021 | kr13m | kr5m | -kr17m |
Sep 30 2021 | n/a | n/a | kr63m |
Jun 30 2021 | n/a | n/a | kr2m |
Mar 31 2021 | n/a | n/a | kr49m |
Dec 31 2020 | kr12m | kr5m | kr82m |
Sep 30 2020 | n/a | n/a | kr86m |
Jun 30 2020 | n/a | n/a | kr87m |
Mar 31 2020 | n/a | n/a | kr55m |
Dec 31 2019 | kr16m | kr2m | kr9m |
Compensation vs Market: Christoffer's total compensation ($USD1.20M) is above average for companies of similar size in the Swedish market ($USD901.38K).
Compensation vs Earnings: Christoffer's compensation has increased whilst the company is unprofitable.
CEO
Christoffer Lorenzen (47 yo)
3.3yrs
Tenure
kr12,564,000
Compensation
Mr. Christoffer Lorenzen has been the Chief Executive Officer of Karo Pharma AB since July 1, 2019. Mr. Lorenzen was an Executive Vice President of Food Cultures & Enzymes at Chr. Hansen Holding A/S from A...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 3.3yrs | kr12.56m | no data | |
Chief Financial Officer | 3.1yrs | no data | no data | |
Vice President of Operations | 3.2yrs | no data | no data | |
Vice President of Scientific Affairs | no data | no data | no data | |
VP of Commercial Pharma Operations & Corporate Communications | no data | no data | no data | |
Chief Marketing Officer | 1.8yrs | no data | no data | |
Head of People & Organization | 2.5yrs | no data | no data | |
Managing Director of Norway | no data | no data | no data | |
Head of Digital & E-commerce | 1.5yrs | no data | no data | |
Chief Commercial Officer | 1.2yrs | no data | no data | |
Chief Executive Officer of Sylphar | less than a year | no data | no data | |
Vice President of Digital Marketing | no data | no data | no data |
2.2yrs
Average Tenure
47yo
Average Age
Experienced Management: KARO's management team is considered experienced (2.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 1.6yrs | kr413.00k | no data | |
Independent Director | 2.5yrs | kr394.00k | no data | |
Director | 3.8yrs | kr394.00k | no data | |
Independent Director | 3.1yrs | kr394.00k | no data | |
Independent Director | 2.5yrs | kr394.00k | no data | |
Independent Chairman | 1.6yrs | kr552.00k | no data | |
Independent Director | less than a year | no data | no data |
2.5yrs
Average Tenure
56yo
Average Age
Experienced Board: KARO's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.